Faster Cures Revenue and Competitors
Estimated Revenue & Valuation
- Faster Cures's estimated annual revenue is currently $7.5M per year.
- Faster Cures's estimated revenue per employee is $277,778
Employee Data
- Faster Cures has 27 Employees.
- Faster Cures grew their employee count by -13% last year.
Faster Cures's People
Name | Title | Email/Phone |
---|---|---|
1 | Associate Director | Reveal Email/Phone |
2 | Director | Reveal Email/Phone |
3 | Associate Director | Reveal Email/Phone |
4 | Senior Director | Reveal Email/Phone |
5 | Associate Director | Reveal Email/Phone |
Faster Cures Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 61 | 9% | N/A | N/A |
#2 | $15M | 102 | N/A | N/A | N/A |
#3 | $35M | 260 | 2% | N/A | N/A |
#4 | $35M | 214 | 2% | N/A | N/A |
#5 | $15M | 118 | 4% | N/A | N/A |
#6 | $15M | 102 | 9% | N/A | N/A |
#7 | N/A | 144 | N/A | N/A | N/A |
#8 | $3.5M | 32 | -11% | N/A | N/A |
#9 | $3.5M | 30 | 3% | N/A | N/A |
#10 | $15M | 151 | -45% | N/A | N/A |
What Is Faster Cures?
FasterCures is an "action tank" committed to building faster tracks to find tomorrow's cures today. Our mission is to clear the path between an idea for treatment and getting a treatment to the patient.
keywords:N/AN/A
Total Funding
27
Number of Employees
$7.5M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Faster Cures News
2022-04-13 - Medicare's Alzheimer's Drug Plan Falls Short on Diversity ...
... centers, Esther Krofah, executive director of FasterCures and the Center for Public Health at the Milken Institute, said in an email.
2022-03-30 - Milken Institute Outlines Next Steps for Mobilizing an Early ...
WASHINGTON--(BUSINESS WIRE)--Recognizing the most effective way to combat the next pandemic is to start planning for it now, FasterCures,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3M | 27 | -46% | $36.4M |
#2 | $2.7M | 27 | N/A | N/A |
#3 | $1.9M | 27 | -31% | $32.5M |
#4 | $4.7M | 27 | N/A | N/A |
#5 | $4.8M | 27 | N/A | N/A |